- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Quiz
Article
Dermatology Times Spot Test: August 17, 2025
Author(s):
Key Takeaways
- Chronic spontaneous urticaria involves spontaneous hives and/or angioedema without identifiable triggers, complicating diagnosis and management.
- Recent research highlights the role of autoimmunity and mast cell activation in CSU pathophysiology, offering new insights.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology.
This week, we'll focus on chronic spontaneous urticaria (CSU) and some of the recent news we've shared about this complex condition.
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at mbosslett@mjhlifesciences.com to contribute!
What is the mechanism of action of remibrutinib, the investigational therapy being studied for CSU?
In the Urticaria Voices study, which country reported the highest impact of CSU on mental and emotional well-being?
What major challenge do randomized controlled trials face in CSU research?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
